INTRODUCTION
Finger Protein 263 (ZFP263). Binding sites for ZFP263, SP family were also identified in the region -168 to -116 (Table 1) .
CV-B4 E2 alters IL-6/STAT3 signaling and decreases STAT3 phosphorylation 177 Given that Signal transducer and activator of transcription 3 (STAT3) acts as positive 178 regulators of Igf2 transcripts in human and in mice (22, 23) , STAT3 protein expression and 179 phosphorylation (STAT3 pY705 ) level were analyzed by Western Blot. Results show that 180 CV-B4 MOI = 0.05 decreases gradually STAT3 pY705 during the course of the infection, 181 whereas STAT3 total was not significantly affected. STAT3 pY705 was decreased of 51% and 182 65% respectively at 2 and 3 days P.I. (Fig. 6A) . In line with this result, Bcl2, a STAT3 183 response gene (24), was similarly decreased during the time course of CV-B4 infection in 184 MTE4-14 ( Fig. 6B) . 185 However, Il6, activator of STAT3 pY705 , was upregulated in infected cells (Fig. 6C) which is 186 in discordance with the observed decrease of STAT3 pY705 . We then investigated 187 expression of the receptor IL6Rα (CD126) by flow cytometry but we were not able to 188 detect a significant difference between mock and infected cells (Fig. 6D) . 189 Previous reports indicate that suppressor of cytokine signaling 3 (SOCS3), a negative 190 regulator of STAT3 activation, is induced by 26) . SOCS3 protein expression 191 was analyzed by Western Blot and was not upregulated during the infection. On the 192 opposite, SOCS3 protein level tends to decrease during the infection (Fig. 6E) . More In this research, we firstly investigate the effect of CV-B4 E2 on Igf2 expression in murine 201 TECs in vivo. The analysis of Igf2 transcripts isoforms in mock inoculated mice revealed 202 that Igf2 V3 and Igf2 V1 are the isoforms which can be mainly detected in CD45enriched 203 TECs. These results corroborate with previous reports on human TECs showing that 204 IGF2 P3 and IGF2 P4, homologous promoter of Igf2 V1 and Igf2 V3 respectively are 205 active in these cells (31) and accordingly, much less Igf2 V2 in CD45enriched TECs was 206 detected. In CV-B4 inoculated mice, both Igf2 V3 and Igf2 V2 were decreased followed 207 by an upregulation of Igf2 V1. These results explained why total Igf2 (representing 208 quantitatively sum of all Igf2 isoforms) was not decreased in infected mice and indicate a 209 differential regulation of Igf2 mRNA transcripts in the thymus by CV-B4 E2. Thus, distinct 210 pathways may regulate Igf2 V3 and V1 mRNA isoforms during CV-B4 infection. This 211 temporal decrease of Igf2 V3 and Igf2 V2 was nevertheless sufficient to achieve a later 212 significant decrease of Pro-IGF2. Consequently a role of CV-B4 on IGF2 presentation in 213 the thymus cannot be excluded, indeed it was shown that CV-B3 is able to alter class I 214 antigen presentation (32). Nevertheless, we were not able to detect any mature IGF2 215 neither in the thymus nor in the TEC cell line MTE4-14. A differential processing of IGF2 216 may occur in the thymus. It was reported that in rat, mature forms of IGF2 are also not 217 found in the brain (33). Moreover, sequencing data of TECs indicates low mRNA 218 expression level of protein convertase PC4 (Pcsk4), enzyme cleaving pro-IGF2 in mature 219 IGF2. A low thymic expression of Pcsk4 would affect IGF2 processing and would allow 220 only the detection of IGF2 immature precursors (34, 35) . In mice inoculated with CV-B4, 221 we were able to detect CV-B4 RNA in the pancreas. However, CV-B4 RNA was not detected in the thymus which is in discordance with previous reports reporting the 223 presence of CV-B4 RNA in the whole thymus (9, 36) . It is likely that the method we 224 employed here for TECs enrichment has interfered negatively with the detection of 225 CV-B4 as it only allows to detect CV-B4 RNA within the cells (Table 2) . Nonetheless, this 226 result indicates that CV-B4 could not replicate as much as expected within murine thymic 227 cells. Of note, attempts to detect CV-B3 replication within cells of murine thymus have 228 similarly failed (37, 38) .
229
Interestingly, several reports show that interferon (IFN)-α or IFN-β are able to decrease 230 Igf2 expression (39-41) and that inactivated CV-Bs virions, by interacting with 231 extracellular Toll-like receptors (TLRs), can still upregulate these interferon suggesting 232 that no replication within cells is actually required to induce IFN expression (42). Thus,
233
CV-B4 draining not replicative virions, within the thymus could induce via TLRs IFN-α or 234 IFN-β which may then alter Igf2 transcripts.
235
The second objective of this study was to explore mechanisms of Igf2 decrease in 236 MTE4-14 cells infected with CV-B4 E2. Similar to the results obtained in vivo, Igf2 V3 and 237 Igf2 V1 are both detected in the cell line with a dominance of Igf2 V3 reflecting a 238 dominant activity of Igf2 P3 and a lower activity of Igf2 P2. Both Igf2 V3 and Igf2 V1 were 239 downregulated concomitantly to the increase of CV-B4 replication and production. Given 240 that Igf2 V1 was on the opposite increased in vivo and CV-B4 E2 viral RNA not replicative 241 (or under the limit of detection) within murine thymic cells, a differential regulation 242 scenario of Igf2 V1 isoforms, possibly related to CV-B4 replication, might takes place in 243 the MTE4-14 cell line, where a higher rate of CV-B4 replication occurred.
244
In this study, we demonstrate that the decrease of Igf2 V3 major isoforms is due to a decrease of Igf2 P3 promoter activity (-168 
METHODS

Cells and virus 284
The murine thymic epithelial cell line MTE4-14, of medullar origin, derived from C3H/J 285 (H-2 k ) thymic neonatal lobes (13), was grown in complete high glucose Dulbecco's 286 modified Eagle medium (DMEM; Gibco) supplemented with 10% heat-inactivated fetal 287 calf serum (FCS; Gibco), 2 mM L-glutamine (Gibco), 0.1 µg/mL epidermal growth factor 288 (EGF; Sigma-Aldrich), 100 U/mL penicillin and 100 µg/mL streptomycin (Gibco) (13, 14) . inoculation, after three freeze/thaw cycles then clarified by centrifugation at 2,500 × g for 296 10 min, filtered and stored at -80 °C.
297
Mice inoculation and infection by CV-B4 E2 298
For in vivo experiment, 4-6 weeks old Swiss Albino female mice were used (Janvier 299 Laboratories). Mice were inoculated by intraperitoneal route with either 100 µL of sterile 300 DPBS (DPBS, Dulbecco's Phosphate-Buffered Saline, Thermo Fisher Scientific) for 301 mock-infected mice or with 100 µL of CV-B4 E2 diluted in sterile DPBS at 1.10 6 302 TCID 50 /mL. Mice were grouped with a maximum of six per cage, checked and weighted 303 daily. Mice were treated according to general ethic rules with unlimited access to food 304 and water. Six infected and mock-infected animals were sacrificed 2, 3 and 7 days P.I. From each animal, thymus and pancreas were collected. All procedures were approved by the university hospital of Liège ethics committee (Protocol n°13-1611).
307
TEC isolation, enrichment and immunostaining 308
Protocol was carried out as previously described (16). Briefly, thymus lobes were cut in as follow: culture supernatants were removed and stored at -20 °C for CV-B4 E2 titration, 343 cells were washed, scrapped in PBS then were processed for RNA or protein extraction.
344
Modified TCID 50 titration assay 345 CV-B4 E2 virus titer was determined on VERO cells by a modified Reed and Muench 346 limiting dilution assay as previously described (56, 57 The 342 bp Igf2 P3 promoter sequence (Fig. 4A) , containing the proximal promoter of the Table 3 -2) and 50 ng of plasmid. The PCR parameters were: one 417 cycle at 98 °C for 30 s; 25 cycles with denaturation step 98 °C for 10 s, annealing (Table   418 3-2) for 30 s and extension step at 72 °C for 150 s and ended at 72 °C for 2 min. Three annealing temperature were performed in parallel for each primer set. PCR products 420 were loaded on 1% agarose gel with Orange DNA Loading Dye 6X (Thermo Fisher 421 Scientific). SYBR safe (Thermo Fisher Scientific) was added on agarose gel at 1:10,000 Igf2 P3 promoter (-168/+175) is set at 100% in each experiment (n = 4-16).
739
Ratio paired t test, *p < 0.05, ***p < 0.001. 
